Raymond James Financial Services Advisors, Inc. Sesen Bio, Inc. Transaction History

Raymond James Financial Services Advisors, Inc.

$73.5 Billion
Q3 2024

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2022 Feb 08, 2023	SELL	$0.49 - $0.61 $364 - $453	-744 Reduced 3.42%	21,000 $12,000
Q3 2022 Oct 25, 2022	BUY	$0.0 - $0.93 $0 - $20,221	21,744 New	21,744 $9,000
Q4 2021 Feb 08, 2022	SELL	$0.73 - $1.28 $16,536 - $28,995	-22,653 Closed	0 $0
Q3 2021 Nov 02, 2021	SELL	$0.77 - $4.91 $197 - $1,256	-256 Reduced 1.12%	22,653 $18,000
Q2 2021 Aug 11, 2021	BUY	$2.18 - $4.66 $3,836 - $8,201	1,760 Added 8.32%	22,909 $106,000
Q1 2021 May 14, 2021	BUY	$1.3 - $3.24 $3,958 - $9,865	3,045 Added 16.82%	21,149 $55,000
Q3 2020 Nov 04, 2020	BUY	$0.67 - $1.4 $12,129 - $25,345	18,104 New	18,104 $25,000

Others Institutions Holding SESN

# of Institutions

Shares Held

Call Options Held

Put Options Held

Concourse Financial Group Securities, Inc. Birmingham, AL

0
Shares

$0
0.0% of portfolio

View Full List

About Sesen Bio, Inc.

Ticker SESN
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 201,702,000
Market Cap $127M
Description
Sesen Bio, Inc., a late-stage clinical company, focuses on designing, engineering, developing, and commercializing targeted fusion protein therapeutics (TFPTs) for the treatment patients with cancer. Its lead product candidates include Vicineum, a locally-administered targeted fusion protein that is in Phase III clinical trials for the treatment...

More about SESN

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Raymond James Financial Services Advisors, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Raymond James Financial Services Advisors, Inc. with notifications on news.

Account